Best Surgical Oncologist in Indore

Brief Profile

Dr. Snita Sinukumar is a Senior Consultant in Surgical Oncology with 12 years of experience, specializing in HIPEC surgery, robotic surgeries, breast cancer surgery, and ovarian cancer treatment. Her expertise includes advanced procedures for gynecological and peritoneal cancers, offering cutting-edge, patient-centered care. Recognized for her contributions to cancer research, she has also received multiple awards for her dedication to work and patient care.

Fields of Experience

• HIPEC Surgery 
• Robotic surgeries 
• Breast Surgeons 
• Ovarian Cancer 

Publications

• Original Article: Sinukumar S, Kammar P, Ray M, Shaikh S, Patel A, Rajan F, Srinivasan A, Damodaran D, Mehta S, Mahajan V, Deo SVS, Bhatt A. Long-Term Survival in Patients Treated by Cytoreductive Surgery with or Without HIPEC for Peritoneal Surface Malignancies-A report from the Indian HIPEC Registry. Indian J Surg Oncol. 2023 Jun;14 (Suppl 1):198-208. doi: 10.1007/s13193-023-01727-7. Epub 2023 Mar 9. PMID: 37359912; PMCID: PMC10284732.
• Original Article: Sinukumar S, Damodaran D, Ray M, Prabhu A, Katdare N, Vikram S, Shaikh S, Patel A, Bhatt A. Cytoreductive Surgery With or Without HIPEC in the Management of Peritoneal Dissemination from Rare Histological Subtypes of Ovarian Cancer - a Retrospective Study by INDEPSO. Indian J Surg Oncol. 2023 Jun;14(Suppl 1):74-81. doi: 10.1007/s13193-022-01640-5. Epub 2022 Sep 7. PMID: 37359936; PMCID: PMC10284742.
• Original Article: Sinukumar S, Damodaran D, Ray M, Mehta S, Paul L, Bhatt A. Pattern of recurrence after interval cytoreductive surgery and HIPEC following neoadjuvant chemotherapy in primary advanced stage IIIC/IVA epithelial ovarian cancer. Eur J Surg Oncol. 2021 Jun;47(6):1427-1433. doi: 10.1016/j.ejso.2021.01.013. Epub 2021 Jan 22. PMID: 33509612.
• Original Article: Bhatt A, Kammar P, Sinukumar S, Parikh L, Jumle N, Shaikh S, Mehta S. Total Parietal Peritonectomy Can Be Performed with Acceptable Morbidity for Patients with Advanced Ovarian Cancer After Neoadjuvant Chemotherapy: Results From a Prospective Multi-centric Study. Ann Surg Oncol. 2021 Feb;28(2):1118-1129. doi: 10.1245/s10434-020-08918-4. Epub 2020 Aug 3. PMID: 32748154
• Case Report: Sinukumar S, Naik S, Khurjekar D, Munde Y, Bhosale S. Pancreaticopleural Fistula After Cytoreductive Surgery and HIPEC for Pseudomyxoma Peritonei-a Rare Presentation and Rare Complication. Indian J Surg Oncol. 2020 Sep;11(Suppl 2):174-177. doi: 10.1007/s13193-020-01149-9. Epub 2020 Jun 26. PMID: 33364691; PMCID: PMC7732892
• Original Article: Sinukumar S, Rajan F, Mehta S, Damodaran D, Zaveri S, Kammar P, Bhatt A. A comparison of outcomes following total and selective peritonectomy performed at the time of interval cytoreductive surgery for advanced serous epithelial ovarian, fallopian tube and primary peritoneal cancer - A study by INDEPSO. Eur J Surg Oncol. 2021 Jan;47(1):75-81. doi: 10.1016/j.ejso.2019.02.031. Epub 2019 Feb 23. PMID: 30857879.
• Original article: Sikora, T.M., Sinukumar, S., Naik, S. et al. Rare Case of Metachronous Gastric Metastasis from Primary Ovarian Carcinoma. Indian J Surg Oncol (2024). https://doi.org/10.1007/s13193-024-01947-5
• Original Article: Sinukumar S, Mehta S, Damodaran D, Rajan F, Zaveri S, Ray M, Katdare N, Sethna K, Patel MD, Kammer P, Peedicayil A, Bhatt A. Failure-to-Rescue Following Cytoreductive Surgery with or Without HIPEC is Determined by the Type of Complication-a Retrospective Study by INDEPSO. Indian J Surg Oncol. 2019 Feb;10(Suppl 1):71-79. doi: 10.1007/s13193-019-00877-x. Epub 2019 Jan 14. PMID: 30886497; PMCID: PMC6397122.
• Original Article: Sinukumar S, Mehta S, As R, Damodaran D, Ray M, Zaveri S, Kammar P, Bhatt A. Analysis of Clinical Outcomes of Pseudomyxoma Peritonei from Appendicular Origin Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy-A Retrospective Study from INDEPSO. Indian J Surg Oncol. 2019 Feb;10(Suppl 1):65-70. doi: 10.1007/s13193-018-00870-w. Epub 2019 Jan 11. PMID: 30886496; PMCID: PMC6397130
• Original Article: Bhatt A, Sinukumar S, Rajan F, Damodaran D, Ray M, Zaveri S, Kammar P, Mehta S. Impact of Radicality Versus Timing of Surgery in Patients with Advanced Ovarian Cancer (Stage III C) Undergoing CRS and HIPEC-a Retrospective Study by INDEPSO. Indian J Surg Oncol. 2019 Feb;10(Suppl 1):57-64. doi: 10.1007/s13193-019-00875-z. Epub 2019 Jan 16. PMID: 30886495; PMCID: PMC6397116.
• Original Article: Bhatt A, Sinukumar S, Mehta S, Damodaran D, Zaveri S, Kammar P, Mishra S, Parikh L, Ranade R, Penumadu P, Rajan F. Patterns of pathological response to neoadjuvant chemotherapy and its clinical implications in patients undergoing interval cytoreductive surgery for advanced serous epithelial ovarian cancer- A study by the Indian Network for Development of Peritoneal Surface Oncology (INDEPSO). Eur J Surg Oncol. 2019 Apr;45(4):666-671. doi: 10.1016/j.ejso.2019.01.009. Epub 2019 Jan 9. PMID: 30661922.
• Original Article: Deraco M, Sinukumar S, Salcedo-Hernández RA, Rajendra VJ, Baratti D, Guaglio M, Nizri E, Kusamura S. Clinico-pathological outcomes after total parietal peritonectomy, cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in advanced serous papillary peritoneal carcinoma submitted to neoadjuvant systemic chemotherapy- largest single institute experience. Eur J Surg Oncol. 2019 Nov;45(11):2103-2108. doi: 10.1016/j.ejso.2019.06.021. Epub 2019 Jun 13. PMID: 31230982.
• Original Article: Nizri E, Baratti D, Guaglio M, Sinukumar S, Cabras A, Kusamura S, Deraco M. Multicystic mesothelioma: Operative and long-term outcomes with cytoreductive surgery and hyperthermic intra peritoneal chemotherapy. Eur J Surg Oncol. 2018 Jul;44(7):1100-1104. doi: 10.1016/j.ejso.2018.03.004. Epub 2018 Mar 14. PMID: 29703622.

Education

• MBBS from Topiwala National Medical College B.Y.LNair Hospital, Mumbai, M.U.H.S University; Aug1999-Dec 2004
• MS. General Surgery from BJ.Medical College , Pune; May2005-June 2008
• Mch. Surgical Oncology from Tata Memorial Hospital, Mumbai, HBNI University; Aug2011-July 2014

Awards and Recognitions

• ‘Best Abstract Award’ for “ Pattern of recurrence  after cytoreductive surgery and HIPEC following neoadjuvant chemotherapy in primary advanced Stage IIIC/IVA epithelial ovarian cancer” at the 12th international PSOGI conference in Spt 10th-13th 2021.
• Awarded  The ‘3rd Surabhi Nag Research Awards 2018’ , with a Grant of Rs 600,000/- for the clinical Proposal Entitled: ’Total Parietal peritonectomy  vs  selective parietal peritonectomy in patients with  advanced ovarian cancer after neoadjuvant chemotherapy.
• Best Poster at PSOGI, Paris, Sept 2018: Failure-to-Rescue Following Cytoreductive Surgery with or Without HIPEC is Determined by the Type of Complication—a Retrospective Study by INDEPSO
• Won the POSTER OF DISTINCTION For ‘CLINICAL OUTCOMES OF PATIENTS UNDERGOING LAPAROSCOPIC VS OPEN SURGERY FOR RECTAL CANCERS’ at the DDF, London, U.K.2015.
• Won the Award for Outstanding Paper for ' A Comparative study between prolene mesh and indegenous moquito net for inguinal hernia repair' At the 52nd Annual conference of the International College of Surgeons-Indian section  held at Cidade Goa on 7th Oct 2006.
• Won the Ratan Tata Scholarship for the Academic year 2006-2007
• Won  the B. Braun award for 'Meritorious Student'  in General Surgery for the academic year 2006-2007

Languages Known

Hindi, English, Marathi, Bengali

Fellowship/Membership

• ESPSO (European Society of peritoneal Surface Oncology)

Past Positions

• Senior Registrar in Surgical Oncology at Tata Memorial Hospital; Aug 2009 to July 2010
• Fellow in Breast Oncology at Tata Memorial Hospital; Aug 2010 to March 2011
• Specialist Registrar in Surgical Oncology at Tata Memorial Hospital; Aug 2014 to July 2015
• Consultant Surgical Oncologist and HIPEC SPECIALIST at Jehangir Hospital, Pune; Aug 2015 to present